MORE►
UT Southwestern Medical Center
Sherry Wang, a professor of statistics and data science, is part of a team from the University of Texas at Arlington and UT Southwestern Medical Center working on a new four-year research project. [Photo: University of Texas at Arlington]
UTA and UT Southwestern Researchers Use AI to Pinpoint Eye Disease ‘Control Switches’
by John Egan | Oct 22, 2026
A $1.96 million National Eye Institute grant funds development of two tools that could help researchers zero in on promising leads for treating macular degeneration, glaucoma and other eye diseases.
by Sandra Engelland |
Aug 27, 2026
Grants of $100,000 or $200,000 went to research projects not chosen for the 2026 Hill Prizes. Six Texas researchers, including three from Dallas’ UT Southwestern Medical Center, shared the $1 million.
MORE►
by Sandra Engelland |
Apr 30, 2026
Participants at the Pegasus Park event had 48 hours to turn early-stage concepts and functional prototypes into actionable solutions "to improve health outcomes, expand access, improve patient experience, and drive system-wide efficiency," Health Wildcatters said.
MORE►
Left to right: Muhammad Rizwan, Ph.D., Assistant Professor of Biomedical Engineering and Ophthalmology at UT Southwestern; Madhukar Patel, M.D., M.B.A., Sc.M., Assistant Professor of Surgery and Surgical Director of the Liver Transplantation Program; and Samuel Achilefu, Ph.D., inaugural Chair of Biomedical Engineering and Professor in the Harold C. Simmons Comprehensive Cancer Center and of Radiology at UT Southwestern [Photos: UTSW]
UT Southwestern Secures Up to $25M ARPA‑H Award to Bioengineer Artificial Livers
by Maddie Preston | Jan 13, 2026
The project, known as Vascularized Immunocompetent Tissue as an Alternative Liver, or VITAL, aims to "biofabricate" functioning livers using patients' own cells and advanced 3D printing techniques.
MORE►
by Quincy Preston |
Oct 15, 2025
Researchers at UTSW identified a set of neurons in the "brain's timekeeper" that may drive nighttime snacking—and in mice, control up to 7% of body weight. The discovery could pave the way for new weight-loss strategies.
MORE►
by Lance Murray |
Sep 18, 2025
UT Southwestern in Dallas will lead three liver cancer projects on prevention, recurrence, and immunotherapy. It joins Mayo Clinic and MD Anderson as a national NCI SPORE site, a program that moves discoveries into clinical trials.
MORE►
by Lance Murray |
Sep 11, 2025
The discovery reveals why people may be more susceptible to infections at certain times of day—and could open new paths for cancer immunotherapy and infection treatments.
MORE►
[Illustration: Sittipol Sukuna/istockphoto]
UT Dallas, UT Southwestern Among Six 2025 iC3 Tech Transfer Showcase Finalists
by David Seeley | Aug 19, 2025
Part of the 2025 iC³ Life Science & Healthcare Innovation Summit to be held September 16-17 in Dallas, the showcase pitch event is designed to connect university researchers with potential investors, industry executives, and strategic partners. This is the first year the showcase has expanded beyond Texas.
MORE►
by Lance Murray |
Aug 18, 2025
The Dallas-based firm will provide program management and oversee construction activity for the new medical campus from Children’s Health and UT Southwestern.
MORE►
by Maddie Preston |
Aug 8, 2025
The funding supports UT Arlington researcher Junzhou Huang, whose team recently ranked first in protein contact prediction and placed sixth overall in an international AI challenge competing against Google DeepMind, the University of Washington, and others.
MORE►
by Lance Murray |
Jul 24, 2025
Using a new tool developed at UT Southwestern Medical Center, researchers identified a gene that seems to be key in regulating food intake, offering a different pathway for potential obesity treatments.
MORE►
Signify Bio co-founders, from left: CEO R.A. Session II and Chief Scientific Officer Daniel Siegwart, Ph.D., of UT Southwestern. {Photos: Taysha Gene Therapies/UTSW]
Dallas’ Signify Bio Launches With Oversubscribed $15M Financing, Partnership With UT Southwestern
by Lance Murray | Jun 5, 2025
Co-founded by Chief Scientific Advisor Daniel J. Siegwart of UT Southwestern and CEO RA Session II, Signify Bio said it harnesses the human body for the production of in situ protein therapeutics. The round was led by Actium Group with participation from the Gates Foundation Strategic Investment Fund, Danaher Ventures LLC, Eli Lilly and Company, and BrightEdge, the American Cancer Society's VC arm.
MORE►
by Lance Murray |
May 25, 2025
The Dallas-based medical center is one of just two in Texas offering osseointegration, a revolutionary implant technique that gives amputees better control, comfort—and for 50-year-old Scott Bryson, the chance to walk his daughter down the aisle.
MORE►
by Lance Murray |
May 6, 2025
To recognize the foundation's "record-breaking" support, the hospital at the new Dallas pediatric campus will be named Moody Children's Hospital upon completion in 2031.
MORE►
by Lance Murray |
May 2, 2025
A UT Southwestern study of blind fruit flies and mice reveals a brain-wide stress response, shedding light on the biological link between sensory loss and dementia.
MORE►
